Hemcheck's Newsletter - November 2022

In November, we continued pushing our commercial activities and strategic collaboration prospects. We have attended several interesting industry congresses and also received several new orders. We have increasing interest in specifically our diagnostic solution which looks promising and we hope to confirm some additional important orders during the coming weeks.

During the month we also signed a new distributor agreement for the Italian market with Levi Biotech. We have already some trials ongoing locally which is very positive. In addition to Italy we are also looking at potential additional distribution agreements for other markets that we do not cover through any partner as of now.
Another positive thing was the ISO 13485 certification that we got early in November.
In this newsletter you can specifically read a bit more about the ISO certification and our commercial activities during the month.

Enjoy the reading!

Joen Averstad


Hemcheck ISO 13485-certified

Hemcheck has received the certification according to the quality standard ISO 13485. The certificate has been issued by RISE, Research Institutes of Sweden AB, and is valid for the next three years. The work to specifically prepare the company for the certification began already in the previous year and the certification process has now been fully completed with a successful result. Achieving ISO 13485 certification is important because it shows that the quality management system in the company is on a high level, and can be requested to enable sales, for example when registering products in certain markets.

Read more


Several follow-up orders in the European market

Cambridge Life Sciences Ltd
UK distributor, Cambridge Life Sciences
Hemcheck has received a follow-up order from its British distributor CLS, Cambridge Life Sciences. The order is of smaller size but shows that CLS is active in the market and that British customers are in demand of Hemcheck’s products.

Read more
Tartu University Hospital, Estonia
Hemcheck has received a follow-up order from Tartu University Hospital in Estonia. The hospital already uses Hemcheck’s products on an ongoing basis and this order means an increase in the number of instruments, which provides a one-time income, while it may mean increased ongoing income for Hemcheck depending on the use. The instruments are intended to be used in the laboratory and in the hematology/oncology department, and both for quality control and diagnostics.

Read more
Czech distributor, Promedicia
Hemcheck has received a small follow-up order from Promedica, a Czech distributor. The order concerns bgs-Test and v-Test.

Read more
Levi Bio
Distribution agreement & follow-up order from its Italian distributor, Levi Biotech
Hemcheck has signed a distributor agreement with Levi Biotech regarding the Italian market. The agreement is for three years and entails a first order during the fourth quarter, like previous similar agreements. In addition Levi Tech has placed a small follow-up order in connection with the signing of the agreement.

Read more about the distribution agreement
Read more about the additional follow-up order

Greek distributor, Anticel
Hemcheck´s Greek distributor Antisel places an additional follow-up order. The order is of lower economic value, but shows again that Antisel is active in the market and that Greek customers demand Hemcheck’s products.

Read more

Update on our commercial activities

We have continued our sales efforts including attending industry meetings and congresses during the month. These are very important in order to meet potential customers, key opinion leaders and potential partners. Below you can find some examples of events we have attended recently.
44th Annual Conference of the Association of Clinical Biochemists in Ireland (ACBI, 2022), 14-15 October in Cork, Ireland.
ACBI 2022 is an annual conference for Clinical Biochemists in Ireland. Hemcheck attended as support to our Irish distributor Cruinn Diagnostics. During the conference the Hemcheck concept was showcased exclusively via a test study performed at Cork University Hospital. Follow up activities are planned with several hospitals in Ireland.

20th Congress of the Polish Society for Laboratory Diagnostics, 19-22 October in Kielce, Poland.
The congress is the main event for laboratory diagnosticians in Poland. Hemcheck attended the congress as support to their Polish partner, Eclipse. They participated as exhibitors, showcasing the Hemcheck concept. Contacts with several interested delegates are being followed up.
ESAIC Focus Meeting, 28-29 October in Barcelona, Spain.
ESAIC is the largest professional community of anaesthesiologists and intensivists in Europe. Hemcheck attended the community as an exclusive exhibitor, supported by their distributor in Spain, SDO Medical. Contacts with several interested delegates from different countries will be followed up by Hemcheck and their distributors/partners in concerned countries.

6th EACTS Mechanical Circulatory Support Summit, 17-19 November in Berlin, Germany
EACTS is the European association of cardio-thoracic surgery and Hemcheck exhibited with our own booth at the meeting, with the focus of showcasing our solution for diagnostic purposes.. Several contacts were made with potential new and current customers as well as potential partners for the German market.

Peter Andersson

Sales & Marketing Manager
Hemcheck_logo_line_preview 2
Contact Us
Hemcheck Sweden AB
Nanna Svartz väg 4
SE-171 65 Solna